GB9204780D0 - Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods - Google Patents

Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods

Info

Publication number
GB9204780D0
GB9204780D0 GB929204780A GB9204780A GB9204780D0 GB 9204780 D0 GB9204780 D0 GB 9204780D0 GB 929204780 A GB929204780 A GB 929204780A GB 9204780 A GB9204780 A GB 9204780A GB 9204780 D0 GB9204780 D0 GB 9204780D0
Authority
GB
United Kingdom
Prior art keywords
vaccinia
pharmaceuticals
reagents
methods
expression products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929204780A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SMITH GEOFFREY L
Original Assignee
SMITH GEOFFREY L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SMITH GEOFFREY L filed Critical SMITH GEOFFREY L
Priority to GB929204780A priority Critical patent/GB9204780D0/en
Publication of GB9204780D0 publication Critical patent/GB9204780D0/en
Priority to AU36418/93A priority patent/AU3641893A/en
Priority to EP93905517A priority patent/EP0656949A1/en
Priority to PCT/GB1993/000460 priority patent/WO1993018153A1/en
Pending legal-status Critical Current

Links

GB929204780A 1992-03-05 1992-03-05 Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods Pending GB9204780D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB929204780A GB9204780D0 (en) 1992-03-05 1992-03-05 Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods
AU36418/93A AU3641893A (en) 1992-03-05 1993-03-05 Vaccinia virus b15r used in interleukin b1-involving condition
EP93905517A EP0656949A1 (en) 1992-03-05 1993-03-05 Vaccinia virus b15r used in interleukin b1-involving condition
PCT/GB1993/000460 WO1993018153A1 (en) 1992-03-05 1993-03-05 Vaccinia virus b15r used in interleukin b1-involving condition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204780A GB9204780D0 (en) 1992-03-05 1992-03-05 Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods

Publications (1)

Publication Number Publication Date
GB9204780D0 true GB9204780D0 (en) 1992-04-15

Family

ID=10711551

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929204780A Pending GB9204780D0 (en) 1992-03-05 1992-03-05 Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods

Country Status (3)

Country Link
EP (1) EP0656949A1 (en)
GB (1) GB9204780D0 (en)
WO (1) WO1993018153A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0412668A (en) * 2003-08-07 2006-09-26 Hoffmann La Roche antigenic air peptides
EP1518932A1 (en) 2003-09-29 2005-03-30 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Modified vaccinia virus Ankara (MVA) mutant and use thereof
WO2020011754A1 (en) * 2018-07-09 2020-01-16 Transgene Chimeric vaccinia viruses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9023352D0 (en) * 1990-10-26 1990-12-05 Lynxvale Ltd Vaccinia vectors,vaccinia genes and expression products thereof

Also Published As

Publication number Publication date
EP0656949A1 (en) 1995-06-14
WO1993018153A1 (en) 1993-09-16

Similar Documents

Publication Publication Date Title
HU9501874D0 (en) Modified cutinases, dna, vector and host
HRP940175A2 (en) Nucleic acid pharmaceuticals
AU3570193A (en) Altered antibodies, products and processes relating thereto
AP9300494A0 (en) Pharmaceuticals
HUP9603071A3 (en) Purin-6-one derivatives, producing and pharmaceuticals preparations containing them
EP0588471A3 (en) Trusted personal computer system with identification.
GB9023352D0 (en) Vaccinia vectors,vaccinia genes and expression products thereof
HU9501771D0 (en) Modified cutinases, dna, vector and host
EP0683821A4 (en) Rna packaging system.
GB9221468D0 (en) Pharmaceuticals
GB8907468D0 (en) Vaccinia vectors,vaccinia genes and expression products thereof
GB9204565D0 (en) Pharmaceuticals
GB9219163D0 (en) Pharmaceuticals
GB9205917D0 (en) Pharmaceuticals
GB9204780D0 (en) Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods
GB9206567D0 (en) Dna analysis
GB9201961D0 (en) Pharmaceuticals
AU6647494A (en) Cytolysin gene and gene product
AU7122694A (en) Dna sequence comprising at least two coat protein genes
ZA932047B (en) Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-N-oxides, process for their preparations and their use as pharmaceuticals.
IE883270L (en) Dna expression vectors
GB9200041D0 (en) Pharmaceuticals
GB9202510D0 (en) Pharmaceuticals
GB9205427D0 (en) Pharmaceuticals
GB9221442D0 (en) Pharmaceuticals